← Back to Clinical Trials
Recruiting NCT06343259

NCT06343259 The Effects of General Versus Spinal Anesthesia on Postoperative Myocardial Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06343259
Status Recruiting
Phase
Sponsor Sisli Hamidiye Etfal Training and Research Hospital
Condition Myocardial Injury After Non-cardiac Surgery
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-04-05
Primary Completion 2024-08-05

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
General AnesthesiaSpinal Anesthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-04-05 with a primary completion date of 2024-08-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this prospective, randomized, single-blind study, we aim to compare the effects of general anesthesia and spinal anesthesia on postoperative myocardial injury in elderly patients undergoing hip surgery. Cardiovascular events are a leading cause of mortality and morbidity following non-cardiac surgery, with myocardial injury after non-cardiac surgery (MINS) being a significant concern. MINS, characterized by asymptomatic elevation of troponin levels without accompanying ECG findings, is closely associated with postoperative mortality. With the increasing prevalence of comorbidities in the elderly population and the rising frequency of non-cardiac surgeries in this demographic, understanding the effects of different anesthesia types on postoperative myocardial injury is crucial.

Eligibility Criteria

Inclusion Criteria: * who will undergo hip surgery * ASAII-III * Over the age of 65 Exclusion Criteria: * Patients diagnosed with sepsis, pulmonary embolism, decompensated heart failure, chronic kidney failure. * Patients who underwent cardioversion in the last 6 months or experienced myocardial infarction. * Patients with a surgical history in the last month. * Patients who required intubation in the intensive care unit. * Patients with a baseline Hs-Troponin T value exceeding 20 ng/L. * Patients with a postoperative peak Hs-Troponin T value higher than baseline.

Contact & Investigator

Central Contact

Mustafa Bilgehan AYIK

✉ drbilgehanayik@gmail.com

📞 +905377247984

Frequently Asked Questions

Who can join the NCT06343259 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Myocardial Injury After Non-cardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06343259 currently recruiting?

Yes, NCT06343259 is actively recruiting participants. Contact the research team at drbilgehanayik@gmail.com for enrollment information.

Where is the NCT06343259 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06343259 clinical trial?

NCT06343259 is sponsored by Sisli Hamidiye Etfal Training and Research Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology